ArticleHuman vaccines & immunotherapeutics2023

A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences.

Jonathan Kitonsa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.